Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and diseases with high unmet need. Founded in 2013, its primary product candidate is tebipenem HBr (tebipenem pivoxil hydrobromide), a potential first oral carbapenem antibiotic for treating complicated urinary tract infections (cUTIs) in adults. The company has an exclusive license agreement with GSK for development, manufacture, and commercialization of tebipenem HBr.
expected 2027-02-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001193125-26-126192 | EDGAR | 100K words |
| 2025-03-27 | 2024-12-31 | 0000950170-25-046125 | EDGAR | 101K words |
| 2024-03-13 | 2023-12-31 | 0000950170-24-030767 | EDGAR | 116K words |
| 2023-03-30 | 2022-12-31 | 0000950170-23-010921 | EDGAR | 115K words |
| 2022-03-31 | 2021-12-31 | 0000950170-22-005194 | EDGAR | 123K words |
| 2021-03-11 | 2020-12-31 | 0001564590-21-012514 | EDGAR | 101K words |
| 2020-03-16 | 2019-12-31 | 0001564590-20-010998 | EDGAR | 110K words |
| 2019-03-14 | 2018-12-31 | 0001564590-19-007805 | EDGAR | 105K words |
| 2018-04-02 | 2017-12-31 | 0001564590-18-007402 | EDGAR | 99K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-11-12 | 2026-09-30 | 0001193125-26-458593 | EDGAR | 71K words |
| 2026-08-12 | 2026-06-30 | 0001193125-26-346795 | EDGAR | 69K words |
| 2025-11-13 | 2025-09-30 | 0001193125-25-280174 | EDGAR | 68K words |
| 2025-08-12 | 2025-06-30 | 0000950170-25-107388 | EDGAR | 68K words |
| 2025-05-13 | 2025-03-31 | 0000950170-25-070380 | EDGAR | 62K words |
| 2024-11-14 | 2024-09-30 | 0000950170-24-127016 | EDGAR | 60K words |
| 2024-08-05 | 2024-06-30 | 0000950170-24-090782 | EDGAR | 58K words |
| 2024-05-15 | 2024-03-31 | 0000950170-24-060400 | EDGAR | 54K words |
| 2023-11-13 | 2023-09-30 | 0000950170-23-062897 | EDGAR | 63K words |
| 2023-08-10 | 2023-06-30 | 0000950170-23-041314 | EDGAR | 62K words |
| 2023-05-11 | 2023-03-31 | 0000950170-23-021187 | EDGAR | 57K words |
| 2022-11-14 | 2022-09-30 | 0000950170-22-024971 | EDGAR | 67K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-11-12 | 0001193125-26-458637 | EDGAR | 1K words |
| 2026-11-10 | 0001193125-26-455789 | EDGAR | 1K words |
| 2026-10-27 | 0001193125-26-434452 | EDGAR | 1K words |
| 2026-08-28 | 0001193125-26-374788 | EDGAR | 1K words |
| 2026-08-12 | 0001193125-26-346855 | EDGAR | 2K words |
| 2026-07-14 | 0001193125-26-302473 | EDGAR | 3K words |
| 2026-03-26 | 0001193125-26-126244 | EDGAR | 3K words |
| 2026-01-30 | 0001193125-26-032004 | EDGAR | 1K words |
| 2025-12-19 | 0001193125-25-325821 | EDGAR | 1K words |
| 2025-11-13 | 0001193125-25-280518 | EDGAR | 2K words |
175 total filings indexed. 144 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001701108 |
| Ticker | SPRO |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.sperotherapeutics.com |
| Listed | 2017-11-02 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/SPRO (~200 tokens, structured JSON with cryptographic provenance)